GAZELLE Trademark

Trademark Overview


On Friday, May 24, 2019, a trademark application was filed for GAZELLE with the United States Patent and Trademark Office. The USPTO has given the GAZELLE trademark a serial number of 88446122. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 25, 2020. This trademark is owned by Chondrial Therapeutics Inc.. The GAZELLE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia

Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases
gazelle

General Information


Serial Number88446122
Word MarkGAZELLE
Filing DateFriday, May 24, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 25, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations; Pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia
Goods and ServicesPharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 10, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 10, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameChondrial Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBala Cynwyd, PA 19004

Trademark Events


Event DateEvent Description
Tuesday, February 25, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 25, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2019NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2019NON-FINAL ACTION WRITTEN
Tuesday, August 13, 2019ASSIGNED TO EXAMINER
Monday, June 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 28, 2019NEW APPLICATION ENTERED IN TRAM